Hospitals and clinics worldwide are leaning further into minimally invasive diagnostics and treatment, and the tools enabling that shift continue to see strong, steady investment. As detailed in the endoscopy device market report, global valuation was recorded at USD 30.87 billion in 2023, rising to an estimated USD 32.60 billion in 2024, with projections placing the market at USD 50.50 billion by 2031. That trajectory reflects a compound annual growth rate of 6.45% across the forecast period, driven by rising gastrointestinal disease incidence, technological innovation, and expanding healthcare expenditure worldwide.
Market Overview
An endoscopy device, or endoscope, is a sophisticated medical instrument used to visually examine the interior of hollow organs and body cavities, with captured images displayed on a monitor for real-time diagnostic and therapeutic use. The broader market encompasses the manufacturing, distribution, and utilization of devices designed for procedures within the gastrointestinal system and beyond, including gastroscopes, colonoscopes, bronchoscopes, and cystoscopes, along with supporting accessories such as light sources, cameras, and biopsy forceps.
These devices serve a wide range of medical specialties — gastroenterology, pulmonology, urology, gynecology, and otolaryngology among them — enabling healthcare professionals to visualize internal structures, perform biopsies, and deliver therapeutic interventions with minimal disruption to the patient. As patient-centric care models continue gaining traction across healthcare systems globally, the role of endoscopy in reducing invasiveness while improving diagnostic accuracy has become increasingly central.
Growth Drivers
The rising global incidence of gastrointestinal disease is a primary catalyst behind this market’s growth. Conditions such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) are becoming more prevalent, driving demand for the accurate diagnostic and therapeutic capabilities that endoscopic procedures provide. This trend, paired with a broader shift toward patient-centric healthcare focused on improved outcomes and lower costs, has accelerated adoption of minimally invasive surgical approaches enabled by modern endoscopy devices.
Continuous innovation in endoscopic lenses and imaging systems is also playing a significant role, with advances in stereoscopic vision and sensing technologies improving resolution and reducing the risk of misdiagnosis. That said, endoscopic procedures still carry inherent risk — including potential infection, bleeding, or organ perforation — and the specialized training required to perform them safely can limit the pace of broader adoption. Even so, the benefits of minimally invasive surgery, including reduced post-operative pain, shorter hospital stays, and faster recovery, continue to outweigh these challenges for most healthcare providers, especially as robotic-assisted systems and customizable tools expand what is clinically achievable.
Emerging Trends
Miniaturization is one of the clearest trends shaping device design today. Compact endoscopy instruments allow for more precise, targeted examination of internal structures while reducing tissue trauma and the risk of complications, ultimately improving patient comfort and accelerating post-procedure recovery. This design philosophy aligns closely with the broader industry push toward less invasive diagnostic and therapeutic techniques.
Semi-automation is another notable development, with manufacturers increasingly integrating computer-assisted image processing directly into endoscopic devices. These systems support real-time analysis and interpretation of visual data during procedures, giving healthcare providers valuable decision-support tools that reduce reliance on individual physician expertise alone while improving diagnostic consistency and accuracy across cases.
Segmentation Insights
By application, the market spans gastroenterology, gynecology, bronchoscopy, laparoscopy, arthroscopy, and others, with gastroenterology leading in 2023 at a valuation of USD 8.88 billion. An aging global population and the rising burden of functional gastrointestinal illnesses are driving sustained demand for diagnostic and therapeutic endoscopic interventions, particularly for conditions such as GERD, irritable bowel syndrome, and colorectal cancer that are more common among older patients.
By type, the market covers endoscopes, endoscopy visualization systems, operative devices, and others, with the endoscopes segment expected to reach USD 25.15 billion by 2031. Their versatility across cancer diagnosis, gastrointestinal disorders, and urinary and lung conditions continues to make them indispensable tools for clinicians, offering less discomfort and faster recovery for patients while enabling more precise interventions.
By end user, the market is classified into hospitals, clinics and ambulatory surgery centers, and other end users, with hospitals projected to see the strongest growth at a 6.20% CAGR through the forecast period. Instruments such as gastroscopes and colonoscopes remain indispensable within hospital settings, particularly in gastroenterology, where they facilitate both diagnosis and treatment through direct visualization of the digestive tract.
Regional Outlook
North America led the global endoscopy device market in 2023, holding roughly 34.56% of total share with a valuation of USD 10.67 billion. Rising prevalence of chronic diseases — including cancer, diabetes, and cardiovascular conditions — combined with a growing geriatric population, has fueled sustained demand for endoscopic procedures across the region, aided further by continued improvements in healthcare infrastructure and the availability of skilled specialists.
Asia-Pacific is projected to be the fastest-growing region, expanding at a 7.39% CAGR to reach an estimated USD 11.71 billion by 2031. Growth here is fueled by the region’s large population base and the rising prevalence of functional gastrointestinal disorders, alongside ongoing improvements in healthcare infrastructure that are making advanced endoscopic procedures more accessible and affordable for patients.
Competitive Landscape
The endoscopy device market remains fragmented, with leading companies including Olympus Corporation, Ethicon, Inc. (Johnson & Johnson), Stryker, Boston Scientific Corporation, FUJIFILM Corporation, KARL STORZ, Smith & Nephew Inc., Medtronic, PENTAX Medical, and Machida Endoscope Co., Ltd competing through continuous innovation, strategic partnerships, and expanding manufacturing capabilities.
Recent developments highlight this dynamic. In March 2024, Scivita Medical Technology Co., Ltd. and Boston Scientific Corporation signed an expanded strategic cooperation agreement covering co-development of future endoscopic devices and exploration of global distribution opportunities for single-use endoscope and imaging technologies. In October 2023, Olympus Corporation launched its next-generation EVIS X1 endoscopy system, designed to significantly enhance the diagnosis and treatment of gastrointestinal conditions.
Outlook
With gastroenterology expected to remain the leading application segment, forecast to reach USD 13.69 billion by 2031, and Asia-Pacific set to outpace other regions in growth, the endoscopy device market appears well-positioned for continued expansion. As imaging technology advances and healthcare systems worldwide double down on preventive care and minimally invasive treatment options, demand for next-generation endoscopy devices is likely to remain robust through the remainder of the decade.
